| Home Market Dynamics Macro Trends Sector Trends Company Insights AI Investing Strategies Sign Up Login |
Sector: Pharmaceuticals
| Eli Lilly is leading advancements in weight loss drug development, bolstered by successful clinical trials of retatrutide, which shows enhanced efficacy over existing treatments. The company's commitment to innovative healthcare initiatives further strengthens its position in the market while catering to community development through enhanced healthcare services. Growing demand for effective weight loss solutions highlights the importance of ongoing product innovation. However, the potential for setbacks in clinical trials remains a concern within the product development landscape. |
| The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at 0.9 is bullish. The market sentiment at 0.1 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next. LLY is likely to move up since both trend sentiment and market sentiment are positive. The positive sentiment force for sector is at 0.4, and the negative at -0.3 on 2026-05-20. The forces of Stock Price Trend (0.9), Option Sentiment (0.8), Sentiment towards Fundamentals (0.7), and Sector Price Trend (0.3) will drive up the price. The forces of Valuation Sentiment (-0.1), Price Level Sentiment (-0.5), and Market Risk Appetite (-0.9) will drive down the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
Sign up to reveice notifications on Market Movers
| LLY | ||||||||||||||
| Date | Attention | Price | StdDev | Price Level | Change | 10 Day Trend | Trend Sentiment | Hourly Trend Sentiment | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-20 | 0%(0%) | 1018.14 | 5.11% | 79 | -0.3% | 0.31% | 0.9 | 0.3 | 1.3% | 0.2 | Long | 55% | 0.7 | -0.5 |
| 2026-05-19 | 0%(0%) | 1021.22 | 4.97% | 83 | 3.34% | 0.33% | 1.5 | 0.6 | 1.2% | 0.4 | Long | 65% | 2.5 | 5.5 |
| 2026-05-18 | 0%(0%) | 988.2 | 5% | 70 | -1.64% | 0.2% | 1 | -0.1 | 1% | 0.6 | Wait | 50% | 2.4 | -8 |
| 2026-05-17 | 0%(0%) | 1.9 | -0.1 | 0.8 | 2.6 | -1 | ||||||||
| 2026-05-16 | 0%(0%) | 1.9 | -0.1 | 0.7 | 2.5 | -1 | ||||||||
| 2026-05-15 | 0%(0%) | 1004.66 | 4.86% | 81 | -0.34% | 0.42% | 1.9 | -0.1 | 0.6% | 0.8 | Long | 65% | 2.1 | -1 |
| 2026-05-14 | 0%(0%) | 1008.04 | 4.66% | 86 | -0.78% | 0.75% | 2.1 | 0.1 | 0.9% | 0.9 | Long | 65% | 1.9 | 4 |
| 2026-05-13 | 0%(0%) | 1015.93 | 4.42% | 95 | 2.63% | 1.72% | 2.9 | 0.7 | 1.7% | 1.1 | Long | 70% | 2.2 | -1 |
| 2026-05-12 | 0%(0%) | 989.94 | 4.18% | 86 | 2.36% | 1.23% | 1.6 | 0.3 | 1.6% | 1 | Long | 65% | 2.5 | -1 |
| 2026-05-11 | 0%(0%) | 967.08 | 4.04% | 76 | 1.96% | 1.06% | 1.3 | -0.2 | 1.2% | 1.1 | Wait | 50% | 3 | -5 |
| Long is the preferred trading strategy with 55% chance of being right. Improving trend sentiment and positive hourly trend. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | ||||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | ||||||||||||||
| Analysis | ||
| ● Eli Lilly (LLY) – Equity Research Report Tue. Mar 17, 2026 | ||
| 2026-05-20 22:51:30 Eli Lilly's posting of promising results ties to a strong company earnings performance. |
| 2026-05-20 22:51:30 The results suggest a potential increase in demand for oral GLP-1 therapies, pointing towards a growing trend in the industry. |
| 2026-05-20 22:51:30 The article discusses Eli Lilly's promising results for their oral GLP-1 product, indicating a positive outlook for its development and market potential. |
| 2026-05-20 17:01:56 How Eli Lilly's leadership handles this legal challenge could significantly impact its reputation and future operations. |
| 2026-05-20 17:01:56 The case may point to broader trends in the pharmaceutical industry regarding drug rebate practices and legality. |
| 2026-05-20 17:01:56 The small decline in stock price may reflect investor reactions to ongoing legal issues and cost concerns. |
| 2026-05-20 17:01:56 The fraud scheme reportedly cost Eli Lilly over $200 million, highlighting significant financial concerns for the company. |
| 2026-05-20 17:01:56 Eli Lilly is involved in a significant legal dispute, alleging fraud in a drug rebate scheme that has serious financial implications. |
| 2026-05-20 11:49:26 The accusation of fraud could negatively affect Eli Lilly’s reputation in the competitive pharmaceutical market. |
| 2026-05-20 11:49:26 The fraud allegations may prompt regulatory scrutiny of drug rebate schemes impacting the pharmaceutical industry. |
| 2026-05-20 11:49:26 Eli Lilly's lawsuit against church bishops and businesses highlights significant legal challenges faced by the company regarding allegations of fraud in drug rebates. |